Asterias Biotherapeutics, Inc. is a biotechnology company revolutionizing the arena of regenerative medicine. Their proprietary cell therapy programs are based on immunotherapy and pluripotent stem cell platform technologies.
Jane Lebkowski, CSO Asterias Biotherapeutics shares her research in Bio stem cells and what she has been developing with her company.
Asterias is presently focused on progressing in three clinical-stage programs which have the potential to address problems in the fields of neurology and oncology.
Listen to this insightful interview and make sure to subscribe, share and review the podcast.